通过MMP-7调节的EMT通路,FXR促进清细胞细胞癌的致癌发生
Jiachen Liu1,2,3,4, Shiyu Huang1,2, Yanguang Hou5
1Department of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Scientific reports
|November 26, 2024
概括
法尔内索伊德X受体 (FXR) 通过调节矩阵金属蛋白酶7 (MMP-7) 和上皮-介质酶过渡 (EMT) 来促进清细胞细胞癌 (ccRCC). 这一发现为ccRCC提供了一种新的治疗策略,与FXR在其他癌症中的已知瘤抑制作用形成对比.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 细胞癌 (RCC),特别是透明细胞RCC (ccRCC),是一种常见的癌症.
- 方氏体X受体 (FXR) 是一个参与基因调节的核受体.
- 尽管已知其参与消化系统瘤和损伤,但FXR在ccRCC发病过程中的作用尚不清楚.
研究的目的:
- 调查FXR在ccRCC发展中的功能性作用.
- 阐明FXR影响ccRCC进展的分子机制.
主要方法:
- 构建FXR过度表达等离子体和小干扰RNA (siRNA) 结构.
- 双露西法酶记者测定证实了FXR与MMP-7促进体结合.
- 鼠标异种移植模型评估FXR对MMP-7和瘤生长的影响.
主要成果:
- FXR直接与矩阵金属蛋白酶7 (MMP-7) 的促进子结合并调节.
- FXR通过MMP-7介导的上皮层-介质细胞转换 (EMT) 途径促进ccRCC的进展.
- 在ccRCC中FXR的作用与其在胃肠道癌症中的典型瘤抑制功能形成鲜明对比.
结论:
- 在ccRCC中,FXR充当瘤基因,通过MMP-7和EMT促进瘤生长.
- 针对FXR可能代表ccRCC治疗的新治疗途径.
- 需要进一步的研究来探索FXR在不同类型癌症中的复杂作用.
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
MAPK Signaling Cascades
5.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K


